Nortem BioGroup releases its annual results for the 2023 financial year
24 September 2024 - 3:05AM
UK Regulatory
Nortem BioGroup releases its annual results for the 2023 financial
year
Nortem BioGroup (EPA:MLBIO) (MLBIO.PA), a
Euronext-listed company and a leader in the European food
biotechnology sector, has released its annual results for the 2023
financial year.
Interested investors can download them at
https://investors.nortembiogroup.com/wp-content/uploads/2024/09/Financial-Report-2023.pdf.
SAFE HARBOR
This press release contains statements regarding the future
of Nortem Biogroup and its innovations. Statements
regarding the future may be accompanied by words such as
"anticipate", "believe", "estimate", "wait", "anticipate",
"pretend", "power", "plan", "potential", the use of future time and
other terms of similar meaning. No undue reliance should be placed
on these claims. These statements involve risks and uncertainties
that could cause actual results to differ materially from those
reflected in such statements, including uncertainty of the
company's commercial success, ability to protect our intellectual
property rights, and other risks. These statements are based on
current beliefs and forecasts and refer only to the date of this
press release. The company assumes no obligation to publicly update
its forward-looking statements, regardless of whether new
information, future events or any other circumstance
arise.
Nortem Biogroup (EU:MLBIO)
Historical Stock Chart
From Dec 2024 to Jan 2025
Nortem Biogroup (EU:MLBIO)
Historical Stock Chart
From Jan 2024 to Jan 2025